Aspire Biopharma Unveils BUZZ BOMB™: A New Era in Pre-Workout Supplements

Aspire Biopharma Holdings, Inc. is set to launch BUZZ BOMB™, a novel sublingual pre-workout supplement, in the third quarter of 2025. This product employs sublingual nano technology to deliver caffeine directly to the bloodstream, providing almost immediate effects. The supplement is available in single-serving packets and comes in six flavors, including Tropical Fruit and Mocha Coffee.

The launch will be highlighted at two major fitness conventions, offering attendees the chance to experience BUZZ BOMB™ firsthand. Aspire's marketing plan emphasizes digital strategies aimed at influencers and traditional sales channels. The pre-workout supplement market is projected to reach $27.97 billion by 2030, growing at a CAGR of 5.9%.

BUZZ BOMB™ aims to disrupt the market with its quick action and convenience, setting it apart from traditional powdered supplements. Aspire's CEO, Kraig Higginson, states that the supplement holds additional appeal in cognitive focus and energy markets, providing a healthy alternative to coffee.